Acer Therapeutics Inc
F:P6NA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Acer Therapeutics Inc
F:P6NA
|
US |
|
Rubis SCA
LSE:0RTS
|
FR |
Shareholder Yield
Current shareholder yield for P6NA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
P6NA Price
Acer Therapeutics Inc
| Average Annual Return | -20.93% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -85% |
| Market Capitalization | 28.8m EUR |
| Shares Outstanding | 35 825 848 |
| Percentage of Shares Shorted |
N/A
|
P6NA Return Decomposition
Main factors of price return
Stock Splits
P6NA's latest stock split occurred on Sep 21, 2017
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, P6NA traded at 0.774 per share. Afterward, the share price was about 8.95.
The adjusted shares began trading on Sep 21, 2017. This was P6NA's 2nd stock split, following the previous one in Sep 29, 2015.
